Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

Journal: Nature Genetics

Published: 2019-02-25

DOI: 10.1038/s41588-018-0342-2

Affiliations: 54

Authors: 54

Go to article
Institutions FC
Channing Division of Network Medicine, BWH, United States of America (USA) 0.11
Department of Health Sciences, University of Leicester, United Kingdom (UK) 0.09
NIH NIEHS Epidemiology Branch, United States of America (USA) 0.06
Department of Clinical Science (K2), UIB, Norway 0.04
Department of Medicine, Arizona, United States of America (USA) 0.04
Division of Pulmonary and Critical Care Medicine, BWH, United States of America (USA) 0.04
Lovelace Respiratory Research Institute (LRRI), United States of America (USA) 0.04
Quebec Heart and Lung Institute (IUCPQ), UL, Canada 0.03
Groningen Research Institute for Asthma and COPD (GRIAC), RUG, Netherlands 0.03
Department of Epidemiology, RUG, Netherlands 0.03
Department of Internal Medicine, SNU, South Korea 0.02
School of Biological Sciences (SBS), UoM, United Kingdom (UK) 0.02
GlaxoSmithKline R&D Collegeville, United States of America (USA) 0.02
Population Health Research Institute, SGUL, United Kingdom (UK) 0.02
National Institute of Tuberculosis and Lung Diseases (NITLD), Poland 0.02
Department of Medicine, NJH CU Anschutz, United States of America (USA) 0.02
UCL Lungs for Living Research Centre (L4L), United Kingdom (UK) 0.02
Department of Medicine, Kangwon National University, South Korea 0.02
Colorado Department of Epidemiology, United States of America (USA) 0.02
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0.02
Department of Epidemiology, JHU, United States of America (USA) 0.02
Seoul Metropolitan Government - Seoul National University Boramae Medical Center (SMG-SNU Boramae Medical Center), SNU, South Korea 0.02
Centre for Heart Lung Innovation (HLI), Canada 0.02
Department of Neurology, BU, United States of America (USA) 0.02
Department of Medicine, BU, United States of America (USA) 0.02
Department of Epidemiology, Erasmus MC, Netherlands 0.02
Department of Medicine, UW, United States of America (USA) 0.01
AstraZeneca Cambridge, United Kingdom (UK) 0.01
Department of Bioanalysis, UGent, Belgium 0.01
Department of Public Health Sciences, UVA, United States of America (USA) 0.01
Center for Public Health Genomics (CPHG), UVA, United States of America (USA) 0.01
Department of Molecular Medicine, UL, Canada 0.01
Department of Neurology, MGH, United States of America (USA) 0.01
VA Boston Healthcare System, United States of America (USA) 0.01
Department of Immunology and Microbiology, CU Anschutz, United States of America (USA) 0.01
Department of Medicine, CU Anschutz, United States of America (USA) 0.01
Colorado Department of Biostatistics and Informatics, United States of America (USA) 0.01
Department of Internal Medicine, UNMC, United States of America (USA) 0.01
Department of Epidemiology, CU, United States of America (USA) 0.01
NIHR Nottingham Respiratory Biomedical Research Centre (BRU), United Kingdom (UK) 0.01
Department of Respiratory Medicine, NUH, United Kingdom (UK) 0.01
Department of Medicine, MU, Thailand 0.01
Center for Genes, Environment and Health (CGEH), NJH CU Anschutz, United States of America (USA) 0.01
Department of Medicine, CU, United States of America (USA) 0.01
Ghent University Hospital, Belgium 0.01
Pulmonary Center, BU, United States of America (USA) 0.01
Framingham Heart Study (FHS), United States of America (USA) 0.01
Department of Biostatistics, UW, United States of America (USA) 0.01
Cardiovascular Health Research Unit (CHRU), United States of America (USA) 0.01
UW Medicine Sleep Center, United States of America (USA) 0.01
Center for Lung Biology, UW, United States of America (USA) 0.01
Erasmus University Medical Center (Erasmus MC), Netherlands 0.01

Return